Peptigenix Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Peptigenix General Information
Description
Developer of peptide-based investigational therapies designed to address chronic disease complications. The company offers research programs in peptide science, discovery platforms for therapeutic development, laboratory capabilities for preclinical evaluation, and investigational approaches targeting metabolic dysfunction and muscle wasting, enabling healthcare providers, research institutions, and patients with severe conditions to access novel therapeutic candidates, improve treatment options, advance clinical understanding, and support long-term disease management.
Contact Information
Website
www.peptigenixllc.comCorporate Office
- 102 Cassia Way
- Henderson, NV 89014
- United States
Corporate Office
- 102 Cassia Way
- Henderson, NV 89014
- United States
Peptigenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Pre-Clinical Trials |
Peptigenix Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Borden Industries | Venture Capital | Minority |
Peptigenix FAQs
-
Where is Peptigenix headquartered?
Peptigenix is headquartered in Henderson, NV.
-
What industry is Peptigenix in?
Peptigenix’s primary industry is Drug Discovery.
-
Is Peptigenix a private or public company?
Peptigenix is a Private company.
-
What is Peptigenix’s current revenue?
The current revenue for Peptigenix is .
-
Who are Peptigenix’s investors?
Borden Industries has invested in Peptigenix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process